KALV stock

Kalvista Pharmaceuticals Inc (KALV) valuation · rev $49.1M

Kalvista Pharmaceuticals Inc (KALV) rev $49.1M.

Cached valuation scalars
MetricValue
Market cap$1.44B
Revenue$49.1M
P/S29.3
P/B49.0
These valuation metrics as JSON? API free 100/day

KALV valuation FAQ

What is KALV's market cap?

Kalvista Pharmaceuticals Inc (KALV) market cap is $1.44B on the latest cached fundamentals snapshot.

What is KALV's latest revenue?

Latest cached Kalvista Pharmaceuticals Inc (KALV) revenue was $49.1M. Statements: https://lician.com/financials/kalv

What is KALV's price-to-sales ratio?

Kalvista Pharmaceuticals Inc (KALV) price-to-sales (P/S) is 29.3, cached market cap $1.44B divided by revenue $49.1M.

What is KALV's price-to-book ratio?

Kalvista Pharmaceuticals Inc (KALV) price-to-book (P/B) is 49.0 on the latest cached fundamentals snapshot.

How many KALV valuation scalars are listed on this page?

This page lists 4 cached valuation scalars for Kalvista Pharmaceuticals Inc (KALV): Market cap, Revenue, P/S, and P/B.

Where is KALV valuation listed?

Cached valuation multiples for Kalvista Pharmaceuticals Inc (KALV) are listed at https://lician.com/valuation/kalv.

Not investment advice. Cached rows, not a live tape.